The NG2 proteoglycan contributes to cell spreading and migration on surfaces coated with type VI collagen. The cytoplasmic domain of the proteoglycan is required for the NG2-dependent component of spreading and migration, suggesting that this domain is involved in transducing signals that influence rearrangements of cytoskeletal machinery. Cell spreading on surface coated with anti-NG2 monoclonal antibodies is now being used to study specific signaling mechanisms activated upon engaged of NG2 by the substratum. This application proposes experiments designed to identify signaling mechanisms mediated by NG2 and to define the impact of these processes on cell behavior.
Specific aim 1 focuses on identifying structural elements of the NG2 cytoplasmic domain that are required for cell spreading. These will be defined by using cells transfected with NG2 cDNAs carrying deletions and mutations in key determinants.
Specific aim 2 probes the role of NG2 in activating rho family GTPases (rho, rac, and cdc42), molecules that control rearrangements of the actin cytoskeleton.
Specific aim 3 examines the SH3 domains. These molecules may provide the link between NG2 and intracellular signaling pathways.
Specific aim 4 investigates the interaction of the C-terminal PDZ-binding of NG2 with cytoplasmic molecules that contain PDZ domains. PDZ domain-containing molecules such as MUPPI, FAP-1 and rhophilin may provide additional links to signaling pathways, as well as serving as scaffolds for the physical localization of NG2 to critical cellular microdomains.

Project Start
2002-05-01
Project End
2003-04-30
Budget Start
Budget End
Support Year
13
Fiscal Year
2002
Total Cost
$200,480
Indirect Cost
Name
Sanford-Burnham Medical Research Institute
Department
Type
DUNS #
009214214
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Yotsumoto, Fusanori; You, Weon-Kyoo; Cejudo-Martin, Pilar et al. (2015) NG2 proteoglycan-dependent recruitment of tumor macrophages promotes pericyte-endothelial cell interactions required for brain tumor vascularization. Oncoimmunology 4:e1001204
Arranz, Amaia M; Perkins, Katherine L; Irie, Fumitoshi et al. (2014) Hyaluronan deficiency due to Has3 knock-out causes altered neuronal activity and seizures via reduction in brain extracellular space. J Neurosci 34:6164-76
Vargas, Lina M; Leal, Nancy; Estrada, Lisbell D et al. (2014) EphA4 activation of c-Abl mediates synaptic loss and LTP blockade caused by amyloid-? oligomers. PLoS One 9:e92309
You, Weon-Kyoo; Yotsumoto, Fusanori; Sakimura, Kenji et al. (2014) NG2 proteoglycan promotes tumor vascularization via integrin-dependent effects on pericyte function. Angiogenesis 17:61-76
Cattaruzza, Sabrina; Ozerdem, Ugur; Denzel, Martin et al. (2013) Multivalent proteoglycan modulation of FGF mitogenic responses in perivascular cells. Angiogenesis 16:309-27
Tigges, Ulrich; Komatsu, Masanobu; Stallcup, William B (2013) Adventitial pericyte progenitor/mesenchymal stem cells participate in the restenotic response to arterial injury. J Vasc Res 50:134-44
Falivelli, Giulia; Lisabeth, Erika Mathes; Rubio de la Torre, Elena et al. (2013) Attenuation of eph receptor kinase activation in cancer cells by coexpressed ephrin ligands. PLoS One 8:e81445
Noberini, Roberta; Koolpe, Mitchell; Lamberto, Ilaria et al. (2012) Inhibition of Eph receptor-ephrin ligand interaction by tea polyphenols. Pharmacol Res 66:363-73
Gibby, Krissa; You, Weon-Kyoo; Kadoya, Kuniko et al. (2012) Early vascular deficits are correlated with delayed mammary tumorigenesis in the MMTV-PyMT transgenic mouse following genetic ablation of the NG2 proteoglycan. Breast Cancer Res 14:R67
Noberini, Roberta; Rubio de la Torre, Elena; Pasquale, Elena B (2012) Profiling Eph receptor expression in cells and tissues: a targeted mass spectrometry approach. Cell Adh Migr 6:102-12

Showing the most recent 10 out of 118 publications